Minocycline hydrochloride extended release - Dr Reddy's Laboratories

Drug Profile

Minocycline hydrochloride extended release - Dr Reddy's Laboratories

Alternative Names: DFD 10; DFD-29; Minocycline HCl extended release - Dr. Reddy's Laboratories/Promius Pharma; Minocycline hydrochloride extended release - Dr. Reddy's Laboratories/Promius Pharma; MINOLIRA

Latest Information Update: 16 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dr Reddys Laboratories
  • Developer Dr Reddys Laboratories; Promius Pharma
  • Class Amides; Antibacterials; Dimethylamines; Neuroprotectants; Small molecules; Tetracyclines
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Acne vulgaris
  • Phase II Rosacea

Most Recent Events

  • 08 May 2017 Registered for Acne vulgaris in USA (PO)
  • 14 Feb 2017 Chemical structure information added
  • 03 Jan 2017 Phase-II clinical trials in Rosacea in Germany (PO) (EudraCT2016-003197-41)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top